Humanized Anti-IL-2 Receptor Monoclonal Antibody in Moderate-to-severe Ulcerative Colitis

Clinical trial NCT00073047 · COMPLETED

Trial details

NCT number: NCT00073047
Sponsor: Facet Biotech
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis Gastrointestinal Disease Inflammatory Bowel Disease

Start date: 2003-04-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.